1-10 of 10
G. Henze
Close
Sort by
Journal Articles

Relationship Between Major Vault Protein/Lung Resistance Protein, Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Drug Resistance in Childhood Leukemia

M.L. den Boer, R. Pieters, K.M. Kazemier, M.M.A. Rottier, C.M. Zwaan, G.J.L. Kaspers, G. Janka-Schaub, G. Henze, U. Creutzig, R.J. Scheper, A.J.P. Veerman
Journal: Blood
Blood (1998) 91 (6): 2092–2098.
https://doi.org/10.1182/blood.V91.6.2092
Published: 1998
Journal Articles

Incidence of TEL/AML1 Fusion Gene Analyzed Consecutively in Children With Acute Lymphoblastic Leukemia in Relapse

J. Harbott, S. Viehmann, A. Borkhardt, G. Henze, F. Lampert
Journal: Blood
Blood (1997) 90 (12): 4933–4937.
https://doi.org/10.1182/blood.V90.12.4933
Published: 1997
Journal Articles

Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group

B Beyermann, AG Agthe, HP Adams, K Seeger, C Linderkamp, G Goetze, WD Ludwig, G Henze
Journal: Blood
Blood (1996) 87 (4): 1532–1538.
https://doi.org/10.1182/blood.V87.4.1532.bloodjournal8741532
Published: 1996
Journal Articles

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia

E Klumper, R Pieters, AJ Veerman, DR Huismans, AH Loonen, K Hahlen, GJ Kaspers, ER van Wering, R Hartmann, G Henze
Journal: Blood
Blood (1995) 86 (10): 3861–3868.
https://doi.org/10.1182/blood.V86.10.3861.bloodjournal86103861
Published: 1995
Journal Articles

Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

A Reiter, M Schrappe, WD Ludwig, W Hiddemann, S Sauter, G Henze, M Zimmermann, F Lampert, W Havers, D Niethammer
Journal: Blood
Blood (1994) 84 (9): 3122–3133.
https://doi.org/10.1182/blood.V84.9.3122.3122
Published: 1994
Journal Articles

Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin- Frankfurt-Munster) Relapse Study Group

C Buhrer, R Hartmann, R Fengler, S Schober, I Arlt, M Loewke, G Henze
Journal: Blood
Blood (1994) 83 (12): 3468–3472.
https://doi.org/10.1182/blood.V83.12.3468.3468
Published: 1994
Journal Articles

Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group

A Reiter, M Schrappe, WD Ludwig, F Lampert, J Harbott, G Henze, CM Niemeyer, H Gadner, S Muller-Weihrich, J Ritter
Journal: Blood
Blood (1992) 80 (10): 2471–2478.
https://doi.org/10.1182/blood.V80.10.2471.2471
Published: 1992
Journal Articles

Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study

R Dopfer, G Henze, C Bender-Gotze, W Ebell, G Ehninger, W Friedrich, H Gadner, T Klingebiel, C Peters, H Riehm
Journal: Blood
Blood (1991) 78 (10): 2780–2784.
https://doi.org/10.1182/blood.V78.10.2780.2780
Published: 1991
Journal Articles

Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group

G Henze, R Fengler, R Hartmann, B Kornhuber, G Janka-Schaub, D Niethammer, H Riehm
Journal: Blood
Blood (1991) 78 (5): 1166–1172.
https://doi.org/10.1182/blood.V78.5.1166.1166
Published: 1991
Journal Articles

Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78

U Creutzig, J Ritter, H Riehm, HJ Langermann, G Henze, H Kabisch, D Niethammer, H Jurgens, B Stollmann, U Lasson
Journal: Blood
Blood (1985) 65 (2): 298–304.
https://doi.org/10.1182/blood.V65.2.298.298
Published: 1985